Abionic Successfully Raises CHF20 Million in Series C Financing

Abionic Successfully Raises CHF20 Million in Series C Financing Network of Eminent High Net Worth Individuals Join Financing Syndicate Financing to Extend Abionic’s Portfolio of Point-of-Care IVD Tests for Critical Care and Emergency Medicine International Clinical Study of World’s Most Rapid Sepsis Test Starts in 14 Hospitals Source: www.businesswire.com - March 28, 2018